This inventor holds 42 USPTO granted patents and 22 published patent applications and 22 EPO patents, primarily in Biotin Assay Technology. Top assignees: Siemens Healthcare Diagnostics Gmbh, Dade Behring Inc.. Active years: 2001-2026.
Location History:
- Bear, DE (US) (2001 - 2012)
- Bear, PA (US) (2012)
- Wilmington, DE (US) (2011 - 2024)
Company Filing History:
Years Active: 2001-2026
Areas of Expertise:
Title: Innovations by Tie Q Wei: A Pioneer in Microfluidics and Biotin Detection
Introduction
Tie Q Wei, based in Wilmington, DE, is an accomplished inventor recognized for his significant contributions to the fields of biochemistry and diagnostics. With a remarkable portfolio of 39 patents, he has positioned himself as a leader in developing innovative technologies that enhance assay methodologies and analytical techniques.
Latest Patents
Two of his latest patents exemplify his innovative spirit and technical expertise. The first patent focuses on "Kits, microfluidics devices, and methods for performing biotin assays." This invention involves kits that contain a chemiluminescent detection system and microfluidics devices aimed at determining the concentration of biotin in samples. The methodology employs a sensitizer capable of generating singlet oxygen in its excited state, with avidin or its analog incorporated, alongside a singlet oxygen-activatable chemiluminescent compound linked directly or indirectly to biotin or its analog.
The second patent, titled "Pretreatment agent in non-agglutination assays," outlines methods and reagents designed to minimize false results in measuring analyte concentrations within samples. This method involves the pretreatment of both the antibody and the sample for non-agglutination immunoassays. The pretreatment agent comprises hydroxyphenyl-substituted C1-C5 carboxylic acids and their metallic salts, along with halogen-substituted counterparts, applied in an effective dose to enhance assay accuracy.
Career Highlights
Throughout his career, Tie Q Wei has made notable waves in the biotech industry. He has worked with several prestigious organizations, including Siemens Healthcare Diagnostics GmbH and Dade Behring Inc., where he has harnessed his expertise to drive advancements in diagnostic technologies.
Collaborations
Tie Q Wei has collaborated with various professionals to further his innovative work. Two significant collaborators include Zhu Teng and Manoj Sharma, both of whom have contributed to the development and enhancement of efficacious diagnostic methods that are now protected by patents.
Conclusion
Tie Q Wei’s extensive patent portfolio and his continuous innovations underscore his commitment to improving diagnostic methodologies. His breakthroughs in microfluidics and assay precision position him as a crucial player in advancing the field of biochemistry, benefiting both scientific research and clinical diagnostics.